{"id":141260,"title":"Guidance Document - Submission and Information Requirements for Extraordinary Use New Drugs (EUNDs) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T22:23:36.974000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/submission-information-requirements-extraordinary-drugs-eunds.html?wbdisable=false","snippet":"Guidance Document - Submission and Information Requirements for Extraordinary Use New Drugs (EUNDs) - Canada.ca Skip to main content Skip to \"About government\" Skip to section menu Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main…","rawSnapshotUrl":"/api/snapshots/raw/141260","browseUrl":"https://replay.healtharchive.ca/job-1/20250418222336/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/submission-information-requirements-extraordinary-drugs-eunds.html?wbdisable=false#ha_snapshot=141260","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}